Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stroke
Pharma
FDA approves Roche's heart attack med TNKase to treat stroke
Roche subsidiary Genentech has added a second stroke treatment to its repertoire, gaining an FDA endorsement for TNKase.
Kevin Dunleavy
Mar 3, 2025 3:19pm
FDA approves Agepha’s version of colchicine for heart disease
Jun 20, 2023 8:10am
Nasal delivery gets antibody to rodent brains to treat stroke
Jan 24, 2023 6:40am
J&J-Legend, Junshi, Vir-WuXi and more—Fierce Pharma Asia
May 27, 2022 9:53am
ACC: Lexicon's sotagliflozin can cut stroke, heart attack
Apr 2, 2022 3:37pm
AstraZeneca's Brilinta wins FDA nod for stroke patients
Nov 6, 2020 11:18am
